Medication without harm WHO Global Patient Safety Challenge Discussion paper for public consultation
Consultation on this discussion paper closed 5 July 2019.
We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.
In March 2017, the World Health Organization (WHO) launched the third Global Patient Safety Challenge (Challenge) with the theme of medication without harm. The goal of the Challenge is to gain worldwide commitment and action to reduce severe, avoidable medication-related harm by 50% in the next five years.
The Australian Government made a commitment to participate in the Challenge, and the Commission is tasked with developing a national response.
The three focus areas of the Challenge are high-risk situations (high-risk medicines), polypharmacy and transitions of care. The high-risk medicines are anti-psychotics, insulin, opioids, heparin and anti-coagulants. More information on the focus areas can be found in the booklet from the WHO, Medication without harm 2017. To download the document visit: https://www.who.int/patientsafety/medication-safety/en/External link
Public consultation on this response closed Friday 5 July 2019.